Stromal communication with cancer cells can influence treatment response. We show that
stromal and breast cancer (BrCa) cells utilize paracrine and juxtacrine signaling to drive …

Tumour metastasis suppressors are inhibitors of metastasis but their mechanisms of action
are generally not understood. We previously showed that the suppressor Raf kinase …

Large-scale sequencing studies are rapidly identifying putative oncogenic mutations in human
tumors. However, discrimination between passenger and driver events in tumorigenesis …

Cancer-associated fibroblasts (CAFs) are abundantly present in the microenvironment of
virtually all tumors and strongly impact tumor progression. Despite increasing insight into their …

Whole genome sequencing (WGS) using fresh-frozen tissue and matched blood samples
from cancer patients may become the most complete genetic tumor test. With the increasing …

Background Molecular tumor boards (MTBs) provide rational, genomics-driven, patient-tailored
treatment recommendations. Worldwide, MTBs differ in terms of scope, composition, …

Invasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response
to chemotherapy. Besides loss of E-cadherin, a hallmark of ILC, genetic inactivation of …

Cigarette smoking is the main risk factor for the development of squamous cell lung carcinoma
(SCC). However, the smoking‐related molecular changes in SCC have not been studied. …

Introduction RET gene fusions are established oncogenic drivers in 1% of NSCLC. Accurate
detection of advanced patients with RET fusions is essential to ensure optimal therapy …

Two decades after the genomics revolution, oncology is rapidly transforming into a genome-driven
discipline, yet routine cancer diagnostics is still mainly microscopy based, except for …